Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...

Fetterman appealed to President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. personally.

Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The Trump administration announced Friday it will not move forward with plans to cover popular weight-loss drugs under ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...